EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Defensin-Rich Platelets Drive Pro-Tumorigenic Programs in Pancreatic Adenocarcinoma

Jonathan Gonzalez-Ruiz iD, Miryam Sarmiento-Casas iD, Ivan Bahena-Ocampo iD, Magali Espinosa iD, Gisela Ceballos-Cancino iD, Karla Vazquez-Santillan iD, Vilma Maldonado iD, Jorge Melendez-Zajgla iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262210898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jonathan Gonzalez-Ruiz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ciencias de la Salud, Universidad Autónoma Metropolitana-Iztapalapa, Mexico City 09310, Mexico. Hauptthemen laut MEDLINE: Blood Platelets, Pancreatic Neoplasms, alpha-Defensins, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación, Consejo Nacional de Humanidades, Ciencias y Tecnologías CONAHCYT, Mexico, CONAHCYT doctoral scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies, driven by late diagnosis, limited therapeutic options, and high metastatic potential. Beyond their canonical roles in hemostasis, platelets have emerged as active modulators of tumor progression and promising noninvasive biomarkers. Among platelet-associated molecules, α-defensins, particularly Defensin Alpha 1/3 (DEFA1/3), have been implicated in inflammation and immunity; however, their contribution to PDAC pathogenesis remains unclear. We combined bioinformatic analysis of platelet transcriptomes with functional and in vivo zebrafish xenograft validation to investigate the impact of DEFA1/3 on PDAC aggressiveness. DEFA1/3 was significantly upregulated in PDAC-derived platelets. Defensin-enriched platelet-like particles (defensin-rich platelets, DRPs) and recombinant DEFA1/3 enhanced pancreatic cancer cell proliferation, migration, and three-dimensional growth in vitro and promoted tumor dissemination in zebrafish xenografts. Transcriptomic profiling revealed the upregulation of SPARC, KDM6A, and GATA6, whereas clinical data from The Cancer Genome Atlas (TCGA)-PDAC linked high DEFA1/3 expression to poor survival, increased immune infiltration, and activation of epithelial–mesenchymal transition (EMT). Platelet-derived DEFA1/3 acts as a functional modulator of PDAC progression, linking platelet granule content to tumor aggressiveness and highlighting a potential biomarker and therapeutic target within the platelet–tumor axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsPancreatic Neoplasmsalpha-DefensinsCarcinoma, Pancreatic DuctalHumansAnimalsZebrafishCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionCell Movement

Stichwörter der Autor:innen

DEFA1/3alpha-defensinspancreatic cancerparticles like-plateletsplateletstranscriptomicstumor progressionzebrafish xenograft

Substanzen

alpha-Defensins

Autor:innen und Institutionen

  • Department of Ciencias de la Salud, Universidad Autónoma Metropolitana-Iztapalapa, Mexico City 09310, Mexico.
  • Laboratorio de Genómica Funcional del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.
  • Laboratorio de Epigenética, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.

ORCID-Profile: Jonathan Gonzalez-Ruiz, Miryam Sarmiento-Casas, Ivan Bahena-Ocampo, Magali Espinosa, Gisela Ceballos-Cancino, Karla Vazquez-Santillan, Vilma Maldonado, Jorge Melendez-Zajgla

Förderung

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación
  • Consejo Nacional de Humanidades, Ciencias y Tecnologías CONAHCYT, Mexico
  • CONAHCYT doctoral scholarship

Zitieren

APA

Gonzalez-Ruiz, J., Sarmiento-Casas, M., Bahena-Ocampo, I., Espinosa, M., Ceballos-Cancino, G., Vazquez-Santillan, K., Maldonado, V., & Melendez-Zajgla, J. (2025). Defensin-Rich Platelets Drive Pro-Tumorigenic Programs in Pancreatic Adenocarcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210898

Vancouver

Gonzalez-Ruiz J, Sarmiento-Casas M, Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Vazquez-Santillan K, et al. Defensin-Rich Platelets Drive Pro-Tumorigenic Programs in Pancreatic Adenocarcinoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210898

BibTeX
@article{GonzalezRuiz2025,
  author = {Gonzalez-Ruiz, Jonathan and Sarmiento-Casas, Miryam and Bahena-Ocampo, Ivan and Espinosa, Magali and Ceballos-Cancino, Gisela and Vazquez-Santillan, Karla and Maldonado, Vilma and Melendez-Zajgla, Jorge},
  title = {Defensin-Rich Platelets Drive Pro-Tumorigenic Programs in Pancreatic Adenocarcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262210898}
}
Kostenlos starten →